Literature DB >> 11020522

Do androgens have a direct effect on endometrial function? An in vitro study.

E M Tuckerman1, M A Okon, T Li, S M Laird.   

Abstract

OBJECTIVE: To test the hypothesis that androgens have a direct effect on the function of endometrial epithelial cells.
DESIGN: In vitro study.
SETTING: Academic research center. PATIENT(S): Endometrial epithelial cells were prepared from biopsy samples obtained from normal fertile women.
INTERVENTIONS: Cells were incubated with androstenedione, testosterone, dihydrotestosterone, and DHEA. MAIN OUTCOME MEASURE(S): Secretion of glycodelin A into the culture fluid was used to assess secretory activity. Uptake of (3)H-thymidine and immunostaining for Ki67 was used to assess cell growth. The specific action of the androgens was confirmed by incubation with an antiandrogen, cyproterone acetate. RESULT(S): Androstenedione (10(-6) M and 10(-7) M) caused a dose-dependent decrease in glycodelin A secretion, uptake of (3)H-thymidine, and percentage of positive Ki67 cells in cultured human endometrial epithelial cells. Testosterone, dihydrotestosterone, and DHEA had no effect on glycodelin A secretion or (3)H-thymidine uptake. The direct effect of androgens on endometrial function were confirmed by demonstrating the presence of androgen receptors in cultured endometrial epithelial cells and showing that the direct effects of the androgens were not observed when cyproterone acetate was added to the cultures. CONCLUSION(S): The results suggest that androstenedione can inhibit human endometrial cell growth and secretory activity. Infertility and miscarriage associated with high androgen levels (e.g., that caused by the polycystic ovary syndrome) may be due to an adverse effect of high androgen levels on the endometrium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020522     DOI: 10.1016/s0015-0282(00)00711-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

Review 1.  Fertility preservation options in transgender people: A review.

Authors:  Natnita Mattawanon; Jessica B Spencer; David A Schirmer; Vin Tangpricha
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

2.  Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study.

Authors:  Tess V Clendenen; Kathryn Hertzmark; Karen L Koenig; Eva Lundin; Sabina Rinaldi; Theron Johnson; Vittorio Krogh; Göran Hallmans; Annika Idahl; Annekatrin Lukanova; Anne Zeleniuch-Jacquotte
Journal:  Horm Cancer       Date:  2016-02-29       Impact factor: 3.869

3.  Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function.

Authors:  K A Walters; K J McTavish; M G Seneviratne; M Jimenez; A C McMahon; C M Allan; L A Salamonsen; D J Handelsman
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

4.  Aromatase inhibitor treatment of menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome.

Authors:  Erin F Wolff; Micah J Hill; William F Simonds; James H Segars
Journal:  Fertil Steril       Date:  2012-09-08       Impact factor: 7.329

5.  Mammary gland and endometrial effects of testosterone in combination with oral estradiol and progesterone.

Authors:  Charles E Wood; Cynthia J Lees; J Mark Cline
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

Review 6.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

7.  Potential action of androstenedione on the proliferation and apoptosis of stromal endometrial cells.

Authors:  Manuel A Maliqueo; Susana Quezada; Marisa Clementi; Ketty Bacallao; Mabel Anido; Cecilia Johnson; Margarita Vega
Journal:  Reprod Biol Endocrinol       Date:  2004-12-10       Impact factor: 5.211

8.  Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome.

Authors:  Xin Li; Bano Pishdari; Peng Cui; Min Hu; Hong-Ping Yang; Yan-Rong Guo; Hong-Yuan Jiang; Yi Feng; Håkan Billig; Ruijin Shao
Journal:  Int J Biol Sci       Date:  2015-11-01       Impact factor: 6.580

9.  Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Naomi E Allen; Timothy J Key; Laure Dossus; Sabina Rinaldi; Anne Cust; Annekatrin Lukanova; Petra H Peeters; N Charlotte Onland-Moret; Petra H Lahmann; Franco Berrino; Salvatore Panico; Nerea Larrañaga; Guillem Pera; Maria-José Tormo; Maria-José Sánchez; J Ramón Quirós; Eva Ardanaz; Anne Tjønneland; Anja Olsen; Jenny Chang-Claude; Jakob Linseisen; Mandy Schulz; Heiner Boeing; Eva Lundin; Domenico Palli; Kim Overvad; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Sheila Bingham; Kay-Tee Khaw; H Bas Bueno-de-Mesquita; Antonia Trichopoulou; Dimitiros Trichopoulos; Androniki Naska; Rosario Tumino; Elio Riboli; Rudolf Kaaks
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

10.  A Randomized Clinical Trial on Comparing The Cycle Characteristics of Two Different Initiation Days of Letrozole Treatment in Clomiphene Citrate Resistant PCOS Patients in IUI Cycles.

Authors:  Nayereh Ghomian; Ashraf Khosravi; Nezhat Mousavifar
Journal:  Int J Fertil Steril       Date:  2015-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.